News Complement Inhibitor Fails in Trials for Geographic Atrophy by Medscape • 2017/11/13 • 0 Comments Complement inhibition as a means of halting the progression of geographic atrophy took a hit this week, with negative findings announced for two pivotal phase 3 clinical trials of lampalizumab. Medscape Medical News Full Story →